Masimo Corporation
MASI
Updated: 23/09/2026, 02:02:04
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
No summaries found.
- Share price
- $179.95
- Market cap
- $9.42B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Catherine Szyman
- Employees
- 7,500
- IPO date
- 08/08/2007
- Beta
- 1.18
- Last dividend
- $0.00
- Day range
- $179.95 – $179.95
- 52-week range
- $125.94 – $179.99
- 1-day performance
- 0.00%
- 1-year performance
- 42.89%
- Current drawdown (1Y)
- -0.02%
- CIK
- 0000937556
- CUSIP
- 574795100
- ISIN
- US5747951003
- Created
- 07/12/2025, 05:10:03
- Last update
- 23/09/2026, 02:02:04
Track Masimo Corporation with an AI analyst
See which prediction-market events move MASI, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Masimo Corporation (NASDAQ:MASI): Earnings Preview, Strategic Acquisition, and Financial Health
Market Data • Market Data • 04/05/2026, 23:00:18
Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones
Zacks Investment Research • STOCK • 01/05/2026, 12:16:23
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
Business Wire • STOCK • 08/04/2026, 00:14:00
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
The Motley Fool • STOCK • 22/03/2026, 14:36:49
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
The Motley Fool • STOCK • 15/03/2026, 19:57:14
Halper Sadeh LLC is Investigating Whether KW and MASI are Obtaining Fair Deals for their Shareholders
GlobeNewsWire • STOCK • 26/02/2026, 13:06:00
Halper Sadeh LLC is Investigating Whether MASI and KW are Obtaining Fair Deals for their Shareholders
GlobeNewsWire • STOCK • 25/02/2026, 17:43:00
Here's Why Masimo (MASI) is a Strong Momentum Stock
Zacks Investment Research • STOCK • 25/02/2026, 11:51:26
Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal
Zacks Investment Research • STOCK • 19/02/2026, 13:06:05
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
Business Wire • STOCK • 18/02/2026, 21:30:00
What's Happening With Masimo Stock?
Forbes • STOCK • 18/02/2026, 10:25:12
Strength Seen in Masimo (MASI): Can Its 34.2% Jump Turn into More Strength?
Zacks Investment Research • STOCK • 18/02/2026, 06:10:14